HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Potentiation of the transient receptor potential vanilloid 1 channel contributes to pruritogenesis in a rat model of liver disease.

Abstract
Persistent pruritus is a common disabling dermatologic symptom associated with different etiologic factors. These include primary skin conditions, as well as neuropathic, psychogenic, or systemic disorders like chronic liver disease. Defective clearance of potential pruritogenic substances that activate itch-specific neurons innervating the skin is thought to contribute to cholestatic pruritus. However, because the underlying disease-specific pruritogens and itch-specific neuronal pathways and mechanism(s) are unknown, symptomatic therapeutic intervention often leads to no or only limited success. In the current study, we aimed to first validate rats with bile duct ligation (BDL) as a model for hepatic pruritus and then to evaluate the contribution of inflammation, peripheral neuronal sensitization, and specific signaling pathways and subpopulations of itch-responsive neurons to scratching behavior and thermal hypersensitivity. Chronic BDL rats displayed enhanced scratching behavior and thermal hyperalgesia indicative of peripheral neuroinflammation. BDL-induced itch and hypersensitivity involved a minor contribution of histaminergic/serotonergic receptors, but significant activation of protein-activated receptor 2 (PAR2) receptors, prostaglandin PGE2 formation, and potentiation of transient receptor potential vanilloid 1 (TRPV1) channel activity. The sensitization of dorsal root ganglion nociceptors in BDL rats was associated with increased surface expression of PAR2 and TRPV1 proteins and an increase in the number of PAR2- and TRPV1-expressing peptidergic neurons together with a shift of TRPV1 receptor expression to medium sized dorsal root ganglion neurons. These results suggest that pruritus and hyperalgesia in chronic cholestatic BDL rats are associated with neuroinflammation and involve PAR2-induced TRPV1 sensitization. Thus, pharmacological modulation of PAR2 and/or TRPV1 may be a valuable therapeutic approach for patients with chronic liver pruritus refractory to conventional treatments.
AuthorsMajedeline Belghiti, Judith Estévez-Herrera, Carla Giménez-Garzó, Alba González-Usano, Carmina Montoliu, Antonio Ferrer-Montiel, Vicente Felipo, Rosa Planells-Cases
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 288 Issue 14 Pg. 9675-9685 (Apr 05 2013) ISSN: 1083-351X [Electronic] United States
PMID23408423 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Receptor, PAR-2
  • TRPV Cation Channels
  • Trpv1 protein, rat
Topics
  • Animals
  • Bile Ducts (surgery)
  • Cholestasis (metabolism)
  • Chronic Disease
  • Hot Temperature
  • Hyperalgesia (metabolism)
  • Liver Diseases (metabolism)
  • Male
  • Mast Cells (pathology)
  • Microscopy, Fluorescence (methods)
  • Models, Neurological
  • Neurons (metabolism, physiology)
  • Pruritus (metabolism)
  • Rats
  • Rats, Wistar
  • Receptor, PAR-2 (metabolism)
  • Signal Transduction
  • TRPV Cation Channels (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: